{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:44:35Z","timestamp":1792568675646,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02740-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:55:58Z","timestamp":1784526958000},"page":"1717-1726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HALP score and risk of renal progression in diabetic kidney disease"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-4539","authenticated-orcid":false,"given":"Muhammed Emre","family":"Sevim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-3791","authenticated-orcid":false,"given":"Pelda Z\u00fcmr\u00fct","family":"Sevim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-2497","authenticated-orcid":false,"given":"Fatma Y\u0131lmaz","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7693-8173","authenticated-orcid":false,"given":"\u015eeyhmus","family":"Ak\u00e7ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9403-7061","authenticated-orcid":false,"given":"Adnan","family":"\u00d6n\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4129-6843","authenticated-orcid":false,"given":"Yunus","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-2906","authenticated-orcid":false,"given":"Z\u00fclf\u00fckar","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-5714","authenticated-orcid":false,"given":"Ya\u015far","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7657-3065","authenticated-orcid":false,"given":"Emre","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2740_CR1","doi-asserted-by":"publisher","first-page":"1699259","DOI":"10.3389\/fnut.2025.1699259","volume":"12","author":"X Yu","year":"2025","unstructured":"Yu X, Liu X, Li H (2025) Nutrient metabolism and complications of type 2 diabetes mellitus: implications for rehabilitation and precision care. Front Nutr 12:1699259. https:\/\/doi.org\/10.3389\/fnut.2025.1699259","journal-title":"Front Nutr"},{"key":"2740_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS, Sehrawat A, Mishra J et al (2022) Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med 184:114\u2013134. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.03.019","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2740_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73","author":"D Fouque","year":"2008","unstructured":"Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391\u2013398. https:\/\/doi.org\/10.1038\/sj.ki.5002585","journal-title":"Kidney Int"},{"issue":"2","key":"2740_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/ijms27021097","volume":"27","author":"RM Zhang","year":"2026","unstructured":"Zhang RM, Caramori ML (2026) Inflammation and Diabetic Kidney Disease. Int J Mol Sci 27(2):1097. https:\/\/doi.org\/10.3390\/ijms27021097","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2740_CR5","doi-asserted-by":"publisher","first-page":"151431","DOI":"10.1016\/j.semnephrol.2023.151431","volume":"43","author":"Y Oda","year":"2023","unstructured":"Oda Y, Nishi H, Nangaku M (2023) Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications. Semin Nephrol 43(3):151431. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151431","journal-title":"Semin Nephrol"},{"key":"2740_CR6","doi-asserted-by":"publisher","first-page":"106710","DOI":"10.1016\/j.phrs.2023.106710","volume":"190","author":"A Petrazzuolo","year":"2023","unstructured":"Petrazzuolo A, Sabiu G, Assi E et al (2023) Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease. Pharmacol Res 190:106710. https:\/\/doi.org\/10.1016\/j.phrs.2023.106710","journal-title":"Pharmacol Res"},{"issue":"657","key":"2740_CR7","doi-asserted-by":"publisher","first-page":"eabj2109","DOI":"10.1126\/scitranslmed.abj2109","volume":"14","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi H, Looker HC, Satake E et al (2022) Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes. Sci Transl Med 14(657):eabj2109. https:\/\/doi.org\/10.1126\/scitranslmed.abj2109","journal-title":"Sci Transl Med"},{"issue":"2","key":"2740_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B et al (2023) Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int 103(2):282\u2013296. https:\/\/doi.org\/10.1016\/j.kint.2022.10.030","journal-title":"Kidney Int"},{"issue":"3","key":"2740_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/nu18030390","volume":"18","author":"P Kleinov\u00e1","year":"2026","unstructured":"Kleinov\u00e1 P, T\u00edmea B, Matej V et al (2026) Nutritional and Metabolic Interventions to Prevent and Treat Protein-Energy Wasting in Nondialysis CKD-Narrative Review. Nutrients 18(3):390. https:\/\/doi.org\/10.3390\/nu18030390","journal-title":"Nutrients"},{"issue":"6","key":"2740_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1053\/j.ajkd.2025.06.019","volume":"86","author":"KL Nowak","year":"2025","unstructured":"Nowak KL, Chonchol M (2025) Targeting Inflammation in CKD. Am J Kidney Dis 86(6):803\u2013813. https:\/\/doi.org\/10.1053\/j.ajkd.2025.06.019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2740_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.14744\/nci.2023.66503","volume":"11","author":"E Karakas","year":"2024","unstructured":"Karakas E, Colak H, Gunes FE et al (2024) Determination of nutritional status and protein-energy wasting in patients with diabetic nephropathy. North Clin Istanb 11(6):560\u2013568. https:\/\/doi.org\/10.14744\/nci.2023.66503","journal-title":"North Clin Istanb"},{"key":"2740_CR12","doi-asserted-by":"publisher","first-page":"1231448","DOI":"10.3389\/fphys.2023.1231448","volume":"14","author":"Q Huo","year":"2023","unstructured":"Huo Q, He T, Xiong J et al (2023) Controlling nutritional status score is associated with renal progression, cardiovascular events, and all-cause mortality in biopsy-proved diabetic kidney disease. Front Physiol 14:1231448. https:\/\/doi.org\/10.3389\/fphys.2023.1231448","journal-title":"Front Physiol"},{"issue":"17","key":"2740_CR13","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/nu14173634","volume":"14","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xiao X, Wu Y et al (2022) Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression. Nutrients 14(17):3634. https:\/\/doi.org\/10.3390\/nu14173634","journal-title":"Nutrients"},{"issue":"1","key":"2740_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13098-024-01536-0","volume":"16","author":"F Zhang","year":"2024","unstructured":"Zhang F, Han Y, Mao Y et al (2024) The systemic immune-inflammation index and systemic inflammation response index are useful for predicting mortality in patients with diabetic nephropathy. Diabetol Metab Syndr 16(1):282. https:\/\/doi.org\/10.1186\/s13098-024-01536-0","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"2740_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","volume":"192","author":"J Tecklenborg","year":"2018","unstructured":"Tecklenborg J, Clayton D, Siebert S et al (2018) The role of the immune system in kidney disease. Clin Exp Immunol 192(2):142\u2013150. https:\/\/doi.org\/10.1111\/cei.13119","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2740_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOT.0000000000000375","volume":"22","author":"PD Winterberg","year":"2017","unstructured":"Winterberg PD, Ford ML (2017) The effect of chronic kidney disease on T cell alloimmunity. Curr Opin Organ Transpl 22(1):22\u201328. https:\/\/doi.org\/10.1097\/MOT.0000000000000375","journal-title":"Curr Opin Organ Transpl"},{"key":"2740_CR17","doi-asserted-by":"publisher","first-page":"109496","DOI":"10.1016\/j.intimp.2022.109496","volume":"114","author":"H Xu","year":"2023","unstructured":"Xu H, Zheng X, Ai J et al (2023) Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol 114:109496. https:\/\/doi.org\/10.1016\/j.intimp.2022.109496","journal-title":"Int Immunopharmacol"},{"key":"2740_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.18632\/oncotarget.28367","volume":"14","author":"CM Farag","year":"2023","unstructured":"Farag CM, Antar R, Akosman S et al (2023) What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP\u2019s prognostic ability in different cancer types. Oncotarget 14:153\u2013172. https:\/\/doi.org\/10.18632\/oncotarget.28367","journal-title":"Oncotarget"},{"issue":"1","key":"2740_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12872-025-04791-9","volume":"25","author":"P Zhao","year":"2025","unstructured":"Zhao P, Zhang Z, Li M et al (2025) Association between Hemoglobin-albumin-lymphocyte-platelet score and all-cause or cardiovascular mortality in patients with diabetes or prediabetes: mediated effects of renal function. BMC Cardiovasc Disord 25(1):331. https:\/\/doi.org\/10.1186\/s12872-025-04791-9","journal-title":"BMC Cardiovasc Disord"},{"key":"2740_CR20","doi-asserted-by":"publisher","first-page":"1173399","DOI":"10.3389\/fendo.2023.1173399","volume":"14","author":"H Pan","year":"2023","unstructured":"Pan H, Lin S (2023) Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999\u20132018. Front Endocrinol (Lausanne) 14:1173399. https:\/\/doi.org\/10.3389\/fendo.2023.1173399","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"03","key":"2740_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1055\/s-0044-1787998","volume":"16","author":"BM Atak Tel","year":"2024","unstructured":"Atak Tel BM, Tel MR, Bilgin S et al (2024) Diagnostic Value of HALP Score in Detecting Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. Ibnosina J Med Biomed Sci 16(03):116\u2013122","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"2740_CR22","doi-asserted-by":"publisher","first-page":"885516","DOI":"10.3389\/fendo.2022.885516","volume":"13","author":"M Tang","year":"2022","unstructured":"Tang M, Cao H, Wei XH et al (2022) Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 13:885516. https:\/\/doi.org\/10.3389\/fendo.2022.885516","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2740_CR23","doi-asserted-by":"publisher","first-page":"21496","DOI":"10.1038\/s41598-025-06540-6","volume":"15","author":"X Ma","year":"2025","unstructured":"Ma X, Qian Y, Qian C et al (2025) Association between inflammation indicators and albuminuria in US adults: a cross-sectional study. Sci Rep 15(1):21496. https:\/\/doi.org\/10.1038\/s41598-025-06540-6","journal-title":"Sci Rep"},{"issue":"19","key":"2740_CR24","doi-asserted-by":"publisher","first-page":"e33650","DOI":"10.1097\/MD.0000000000033650","volume":"102","author":"F Zhang","year":"2023","unstructured":"Zhang F, Li L, Shi T et al (2023) The hemoglobin, albumin, lymphocyte, and platelet (HALP) is a potent indicator for the prognosis in hemodialysis patients. Med (Baltim) 102(19):e33650. https:\/\/doi.org\/10.1097\/MD.0000000000033650","journal-title":"Med (Baltim)"},{"key":"2740_CR25","doi-asserted-by":"publisher","unstructured":"Xing L, Xie F, Zhong Z et al (2024) Hemoglobin, Albumin, Lymphocyte, and Platelet Score Correlates with the Occurrence and Prognosis of Diabetic Kidney Disease Patients: Data from Two Large Cohorts. Preprints 2024111717. https:\/\/doi.org\/10.20944\/preprints202411.0717.v1","DOI":"10.20944\/preprints202411.0717.v1"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02740-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:32:53Z","timestamp":1792567973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02740-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2740"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02740-2","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Dicle University Faculty of Medicine Hospital Non-Interventional Clinical Research Ethics Committee (decision no. 345, dated September 17, 2025) and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective design of the study, the requirement for written informed consent was waived by the ethics committee.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}